UBS Group
VINCW

UBS Group’s Vincerx Pharma, Inc. Warrant VINCW Stock Holding History

UBS Group’s Portfolio VINCW Stock Details VINCW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,227
Closed -$5K – 10363
2021
Q1 		$5K Buy
1,227
+295
+32% +$1.19K ﹤0.01% 8390
2020
Q4 		$3K Buy
+932
New +$3.1K ﹤0.01% 8064

UBS Group's VINCW Position: Q2 2021 in Review

UBS Group sold out of Vincerx Pharma, Inc. Warrant (VINCW) in Q2 2021, closing a stake of 1,227 shares — an estimated $5K sold.

UBS Group first reported a position in VINCW in Q4 2020 and held it in 2 quarters. The position peaked at $5K in Q1 2021. 0 funds tracked by Wall St. Rank hold VINCW as of Q2 2021.

  • UBS Group reported no remaining Vincerx Pharma, Inc. Warrant position as of Q2 2021 after selling out during the quarter.
  • UBS Group sold 1,227 Vincerx Pharma, Inc. Warrant shares in Q2 2021, an estimated $5K.
  • UBS Group first reported a position in Vincerx Pharma, Inc. Warrant in Q4 2020 and held it in 2 quarters.
  • UBS Group's Vincerx Pharma, Inc. Warrant position peaked at $5K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Warrant as of Q2 2021.

Based on UBS Group's 13F filing for Q2 2021, filed 13 Aug 2021.